News of Note—Anthem will cover artificial pancreas; Takeda posts update on depression-monitoring smartwatch study

newspaper

> Anthem, the second-largest insurance company nationwide, will cover artificial pancreas systems. Drug Delivery Business News story

> Takeda and Cognition Kit reported strong compliance in 30-person trial investigating the use of the Apple Watch to monitor people with major depressive disorder. Release | Read more from FierceMedTech

> The FDA cleared Kaléo’s AUVI-Q 0.1 mg Auto-injector, the first and only epinephrine autoinjector designed to treat allergic reactions in infants and small children. Release

INDUSTRY RESEARCH

Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.